ID
23149
Description
Study ID: 100551 (EXT Y11) Clinical Study ID: 100551 Study Title: A double blind randomised, comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B vaccine when administered in healthy adults Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289770 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B
Keywords
Versions (3)
- 6/26/17 6/26/17 -
- 9/26/17 9/26/17 -
- 9/20/21 9/20/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 26, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B (Visit 17 Year 11)
Comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B (Visit 17 Year 11)
Description
General Information
Description
Demographics
Description
Center number
Data type
integer
Description
Date of birth
Data type
date
Description
Gender
Data type
text
Description
Race
Data type
text
Description
Specification of other race
Data type
text
Description
Laboratory tests
Description
Blood sample
Data type
text
Description
Date of blood sample (if different from visit date)
Data type
date
Description
Hepatitis A or Hepatitis B vaccine
Data type
text
Description
Specification of received Hepatitis A or Hepatitis B vaccine
Data type
text
Description
Hepatitis A or Hepatitis B immunoglobulins within 6 months prior to bleeding
Data type
text
Description
Specification of Hepatitis A or Hepatitis B immunoglobulins within 6 months prior to bleeding
Data type
text
Description
Study Conclusion
Description
Follow-up studies
Data type
text
Description
Specification of the most appropriate reason the subject is not willing to participate in a follow-up study
Data type
text
Description
Specification of Adverse Events or Serious Adverse Events
Data type
text
Description
Specification of other reason for not willing to participate in a follow-up study
Data type
text
Description
Serious Adverse Event
Description
Investigator´s signature
Description
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below
Data type
text
Description
Date
Data type
date
Description
Printed investigator´s name
Data type
text
Description
Tracking Document - Reason for non participation
Description
Previous Subject Number
Data type
integer
Description
Date of Birth
Data type
date
Description
Reason for non participation
Data type
integer
Alias
- UMLS CUI [1]
- C3166257
Description
Eligibility
Data type
text
Description
Specification of adverse event or serious adverse event
Data type
text
Description
Specification of other reason for non participation
Data type
text